Veteran Runs Psilocybin Retreats for PTSD Ahead of FDA Approval
Jesse Gould, an Army Ranger veteran who suffered traumatic brain injuries and PTSD during deployments in Afghanistan, established the Heroic Hearts Project to offer psilocybin and ayahuasca retreats for veterans. Dissatisfied with traditional maintenance medications and talk therapy, Gould sought alternative treatments after finding relief through psychedelics in Peru. His non-profit aims to prevent veteran suicides by providing access to these substances, which are not yet FDA-approved for therapeutic use. While researchers indicate that psilocybin can disrupt harmful neural patterns and alleviate trauma symptoms, they urge caution regarding widespread legalization before federal approval. Despite this, states like Colorado, Oregon, and New Mexico have legalized therapeutic use, with several others considering similar legislation. Proponents, including bipartisan lawmakers, argue that psychedelic-assisted therapy offers crucial tools for treating PTSD and depression where conventional methods fall short. Clinical studies suggest psilocybin, when administered with psychological support, is safe and effective for symptomatic improvement in adults with PTSD, highlighting a growing movement to integrate psychedelic medicine into mental health care for veterans.
Wire timeline
Veteran Runs Psilocybin Retreats for PTSD Ahead of FDA Approval
Jesse Gould, an Army Ranger veteran who suffered traumatic brain injuries and PTSD during deployments in Afghanistan, established the Heroic Hearts Project to offer psilocybin and ayahuasca retreats for veterans. Dissatisfied with traditional maintenance medications and talk therapy, Gould sought alternative treatments after finding relief through psychedelics in Peru. His non-profit aims to prevent veteran suicides by providing access to these substances, which are not yet FDA-approved for therapeutic use. While researchers indicate that psilocybin can disrupt harmful neural patterns and alleviate trauma symptoms, they urge caution regarding widespread legalization before federal approval. Despite this, states like Colorado, Oregon, and New Mexico have legalized therapeutic use, with several others considering similar legislation. Proponents, including bipartisan lawmakers, argue that psychedelic-assisted therapy offers crucial tools for treating PTSD and depression where conventional methods fall short. Clinical studies suggest psilocybin, when administered with psychological support, is safe and effective for symptomatic improvement in adults with PTSD, highlighting a growing movement to integrate psychedelic medicine into mental health care for veterans.
The Guardian